Wednesday, 30 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q3 FY26

Samrat Pharmachem Q3 FY26 Results: Net Loss of ₹0.5 Cr

Samrat Pharmachem Ltd reported a net loss of ₹0.5 Cr for Q3 FY26.

Q3 FY26 at a glance · ₹ crore
MetricQ3 FY26Q2 FY26Q3 FY25
Other income0.40.00.0
Total income63.878.963.7
Net profit-0.5-0.62.8
Operating margin-0.9%-0.9%6.1%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Source

BSE results filing, NSE: SAMRATPH. Figures extracted from the filing.

Read the filing ↗

Samrat Pharmachem Ltd: key numbers

Share price
₹235.95
Market cap
₹72.90 Cr
Revenue (annual)
₹289.7 Cr
Net profit (annual)
₹-3.31 Cr
P/E (TTM)
-33.0×Sector 49.8×
Promoter holding
49.09%+0.00% QoQ
FII holding
3.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Samrat Pharmachem Ltd

All →
15:02 IST BSE
Board Meeting Date

Samrat Pharmachem Board Meeting Date

Samrat Pharmachem will hold a board meeting on November 14, 2026, to consider its unaudited quarterly financial results for the period ended September 2026.

16:15 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.

16:37 IST BSE
Annual General Meeting

Samrat Pharmachem Annual General Meeting

Samrat Pharmachem Limited held its 34th Annual General Meeting on September 23, 2026. The meeting successfully transacted the business items outlined in the prior meeting notice.

20:37 IST BSE
Annual General Meeting

Samrat Pharmachem Annual General Meeting

Samrat Pharmachem will hold its 34th Annual General Meeting on September 23, 2026, via video conferencing. The company also announced book closure dates for shareholders.

20:04 IST BSE
Annual Report

Samrat Pharmachem Annual Report

Samrat Pharmachem filed its 34th Annual Report for FY 2025-26. The company's 34th AGM is scheduled for September 23, 2026, via video conferencing.